Skip to menu Skip to content Skip to footer
Dr

Yufan Wang

Email: 

Overview

Background

I am a Research Fellow in Health Economics at the University of Queensland’s Centre for the Business and Economics of Health (CBEH). My research focuses on the economic evaluation of varying healthcare interventions for cancer, with interests in exercise oncology, precision medicine, and implementation science. I am dedicated to advancing the long-term wellness of women following cancer treatment, specifically by identifying the cancer rehabilitation programs that provide the best value for money for this population. Additionally, I explore the role of therapeutic radiopharmaceuticals in cancer treatment, seeking to develop innovative cost-effective analysis that enable more robust evaluation of these novel therapies at the production stage.

Availability

Dr Yufan Wang is:
Available for supervision

Qualifications

  • Bachelor of Science in Economics, Singapore Management University
  • Masters (Coursework) of Health Economics, The University of Queensland
  • Doctor of Philosophy of Health Economics, The University of Queensland

Research interests

  • Health technology assessment

    systematic evaluation of efficacy and cost-effectiveness of novel health services

  • Value of information and implementation analysis

    quantify decision uncertainty to optimise reimbursement decisions for high value-added health services

  • Structured expert elicitation

    extract expert opinions into probabilistic distributions as evidence inputs for healthcare decision-modelling

  • Cancer economics

    evaluate the health and economic impact of novel cancer therapies to promote equitable public access

  • Implementation Science

    translate evidence-based practices into real-world healthcare and policy

Research impacts

  • I am an evaluator in the health technology assessment team at CBEH that evaluates submissions made to the Australian and Singapore governments to reimburse new drugs and medical devices.
  • In 2023, I published the first cost-utility analysis of a supervised exercise intervention designed for Australian women with early-stage endometrial cancer. The study shows that the proposed exercise program had a 99.5% likelihood to be cost-effective at a WTP threshold of AUD $50,000 over a time-horizon of 5 years.
  • I led the first co-designed Structured Expert Elicitation (SEE) with clinicians in exercise oncology, successfully eliciting three key uncertain quantities. This co-design approach enhanced the feasibility and acceptability of SEE in Australian clinical research.
  • I am collaborating with the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) to develop new economic evaluation frameworks to assess the early value for money of manufactured radiopharmaceuticals at end-stage production.

Works

Search Professor Yufan Wang’s works on UQ eSpace

7 works between 2022 and 2024

1 - 7 of 7 works

Featured

2024

Other Outputs

Assessing the value for money of integrating exercise as therapy after gynaecological cancer treatment

Wang, Yufan (2024). Assessing the value for money of integrating exercise as therapy after gynaecological cancer treatment. PhD Thesis, School of Nursing, Midwifery and Social Work, The University of Queensland. doi: 10.14264/23460ca

Assessing the value for money of integrating exercise as therapy after gynaecological cancer treatment

Featured

2023

Conference Publication

Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer

Wang, Yufan, McCarthy, Alexandra L. and Tuffaha, Haitham (2023). Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer. HTAi 2023 Meeting, Adelaide, SA Australia, 24-28 June 2023. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s0266462323001277

Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer

Featured

2023

Journal Article

Economic evaluation of exercise interventions for individuals with cancer: a systematic review

Wang, Yufan, McCarthy, Alexandra L., Hayes, Sandra C., Gordon, Louisa G., Chiu, Vivian, Bailey, Tom G., Stewart, Elizabeth and Tuffaha, Haitham (2023). Economic evaluation of exercise interventions for individuals with cancer: a systematic review. Preventive Medicine, 172 107491, 1-8. doi: 10.1016/j.ypmed.2023.107491

Economic evaluation of exercise interventions for individuals with cancer: a systematic review

Featured

2023

Journal Article

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

Wang, Yufan, McCarthy, Alexandra L and Tuffaha, Haitham (2023). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. Supportive Care in Cancer, 31 (7) 391, 391. doi: 10.1007/s00520-023-07819-y

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

Featured

2022

Conference Publication

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

Wang, Yufan, McCarthy, Alexandra and Tuffaha, Haitham (2022). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

2024

Conference Publication

Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework

Wang, Yufan, McCarthy, Sandie and Tuffaha, Haitham (2024). Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework

2024

Journal Article

Establishment and assessment of an oral squamous cell carcinoma N7-methylguanosine methyltransferase associated microRNA prognostic model

Li, Jianrong, Li, Chu, Li, Xiaolian, Chen, Yuling, Li, Zhangfu, Lin, Yuntao, Jing, Huan, Wang, Yufan and Yang, Hongyu (2024). Establishment and assessment of an oral squamous cell carcinoma N7-methylguanosine methyltransferase associated microRNA prognostic model. Journal of Cancer, 15 (18), 6022-6037. doi: 10.7150/jca.98350

Establishment and assessment of an oral squamous cell carcinoma N7-methylguanosine methyltransferase associated microRNA prognostic model

Supervision

Availability

Dr Yufan Wang is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr Yufan Wang's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au